Northpond Ventures, LLC Candel Therapeutics, Inc. Transaction History
Northpond Ventures, LLC
- $28.9 Million
- Q2 2024
A detailed history of Northpond Ventures, LLC transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Northpond Ventures, LLC holds 1,935,215 shares of CADL stock, worth $14 Million. This represents 41.58% of its overall portfolio holdings.
Number of Shares
1,935,215
Previous 1,935,215
-0.0%
Holding current value
$14 Million
Previous $3.06 Million
292.48%
% of portfolio
41.58%
Previous 8.58%
Shares
1 transactions
Others Institutions Holding CADL
# of Institutions
49Shares Held
5.97MCall Options Held
82.9KPut Options Held
56K-
Black Rock Inc. New York, NY823KShares$5.93 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA819KShares$5.9 Million0.0% of portfolio
-
State Street Corp Boston, MA473KShares$3.41 Million0.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA406KShares$2.93 Million1.27% of portfolio
-
Geode Capital Management, LLC Boston, MA398KShares$2.87 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $208M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...